Nathan Richoz
MRC Laboratory of Molecular Biology(GB)University of Cambridge(GB)
Publications by Year
Research Areas
Immune cells in cancer, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, SARS-CoV-2 and COVID-19 Research, Cancer, Stress, Anesthesia, and Immune Response
Most-Cited Works
- → Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity(2022)1,150 cited
- → SARS-CoV-2 evolution during treatment of chronic infection(2021)1,069 cited
- → Cross-tissue immune cell analysis reveals tissue-specific features in humans(2022)1,068 cited
- → Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors(2018)806 cited
- → Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2(2021)803 cited
- → Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies(2021)712 cited
- → Spatiotemporal immune zonation of the human kidney(2019)442 cited
- → A thermostable, closed SARS-CoV-2 spike protein trimer(2020)354 cited
- → Spatially resolved multiomics of human cardiac niches(2023)347 cited
- → Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis(2020)207 cited